Impact of SARS-CoV-2 on Provided Healthcare. Evidence From the Emergency Phase in Italy

Frontiers in Public Health

Americo Cicchetti¹  Rossella Di Bidino² 

[1] Graduate School of Health Economics and Management (Alta Scuola di Economia e Management dei Sistemi Sanitari), Universitá Cattolica del Sacro Cuore, Rome, Italy;Health Technology Assessment Unit, Fondazione Policlinico Universitario Agostino Gemelli Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy;

关键词: COVID-19;    SARS-CoV2;    cancer care;    cardiology;    Health Services Research;    Response model (RM);   

DOI  :  10.3389/fpubh.2020.583583

来源: DOAJ

【 摘 要 】

The SARS-CoV-2 (COVID-19) pandemic led to an emergency scenario within all aspects of health care, determining reduction in resources for the treatment of other diseases. A literature review was conducted to identify published evidence, from 1 March to 1 June 2020, regarding the impact of COVID-19 on the care provided to patients affected by other diseases. The research is limited to the Italian NHS. The aim is to provide a snapshot of the COVID-19 impact on the NHS and collect useful elements to improve Italian response models. Data available for oncology and cardiology are reported. National surveys, retrospective analyses, and single-hospital evidence are available. We summarized evidence, keeping in mind the entire clinical pathway, from clinical need to access to care to outcomes. Since the beginning, the COVID-19 pandemic was associated with a reduced access to inpatient (−48% for IMA) and outpatient services, with a lower volume of elective surgical procedures (in oncology, from 3.8 to 2.6 median number of procedures/week). Telehealth may plays a key role in this, particularly in oncology. While, for cardiology, evidence on health outcome is already available, in terms of increased fatality rates (for STEMI: 13.7 vs. 4.1%). To better understand the impact of COVID-19 on the health of the population, a broader perspective should be taken. Reasons for reduced access to care must be investigated. Patients fears, misleading communication campaigns, re-arranged clinical pathways could had played a role. In addition, impact on other the status of other patients should be mitigated.

【 授权许可】

Unknown